Get the app
US › Healthcare

Seer Inc (SEER)

US · Healthcare · Biotechnology

$2.03-0.49%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$3.1M
Revenue YoY
-21.1%
Net profit
$-16.9M
EPS
$-0.31
EPS estimate
$-0.27
Net margin
-544.8%

EPS came in at -0.31 against a street estimate of -0.27 — a miss of 14.8%.

Key statistics

Market cap
$119.0M
Forward P/E
0.0
P/B
0.45
Book value
$4.08
EPS (TTM)
$-1.25
52-week high
$2.41
52-week low
$1.55
50-day MA
$2.05
200-day MA
$1.91
Beta
1.47

Analyst view

Analysts rate Seer Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $4.00.

Shareholding

Insiders
14.65%
Institutions
50.68%

Largest institutional holders

FundStake
SoftBank Group Corp9.27%
Siren, L.L.C.4.44%
Acadian Asset Management LLC3.53%
Vanguard Capital Management, LLC3.31%
BlackRock Inc2.58%
Renaissance Technologies Corp1.78%
NANO CAP NEW MILLENNIUM GROWTH FUND L P1.49%
AJU IB Investment Co Ltd1.47%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Seer Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-10-19.